Genotype specific detection of Chlamydophila psittaci

• US 20060008828A1
• Filed: 06/30/2005
• Published: 01/12/2006
• Est. Priority Date: 06/30/2004
• Status: Abandoned Application

• Current Assignee: Daisy Vanrompay
• Original Assignee: Daisy Vanrompay
• Inventors: Vanrompay, Daisy
• Application Number:
  US11/171,113
• Publication Number:
  US 20060008828A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/689 for bacteria

Abstract

The present invention describes novel methods for the specific detection and identification of Chlamydophila psittaci genotypes. According to one embodiment the method makes use of quantitative PCR with internal probes and optionally competitor probes which increase specificity. The invention also describes a strain of Cp. psittaci with a novel genotype EB and methods to distinguish said novel genotype from previously identified genotypes.

Claims

1. An ex vivo or in vitro method for the identification of the presence of DNA of a genotype of Cp. psittaci in a sample, said method comprising the steps of:

incubating said sample with a first oligonucleotide which is capable of specifically hybridising to DNA of a genotype of Cp. psittaci, and,

determining the binding of said first oligonucleotide to DNA within said sample, which binding is indicative of the presence of DNA of a genotype of Cp. psittaci in said sample.

2. The method according to claim 1, wherein said first nucleotide comprises a sequence of at least 15 nucleotides of the OmpA gene of one of the Cp. psittaci genotypes.

3. The method according to claim 1, wherein said first nucleotide comprises a sequence of at least 15 nucleotides within the region from about nucleotide 450 to about nucleotide 600 or from about nucleotide 900 to about 1100 of the OmpA sequence corresponding to GB accession AF269281.

4. The method of claim 1, wherein said genotype of Cp. psittaci is selected from genotypes A, B, C, D, E, F and EB.

5. The method according to claim 1, wherein said first oligonucleotide is labeled with a chromophoric group at its 5′

and with a quencher group at its 3′

end.

6. The method of claim 1, wherein said sample is incubated with more than one first oligonucleotide, and wherein each of said more than one first nucleotide is capable of hybridising to DNA of a genotype of Cp. psittaci.

7. The method according to claim 1, wherein the first oligonucleotide comprises a sequence selected from the group consisting of:

sequence corresponding to SEQ ID NO;

1 for genotype A,

sequence corresponding SEQ ID NO;

2, for genotype B,

sequence corresponding SEQ ID NO;

3 for genotype C,

sequence corresponding SEQ ID NO;

4, for genotype D,

sequence corresponding SEQ ID NO;

5, for genotype E,

sequence corresponding SEQ ID NO;

6, for genotype F and

sequence corresponding SEQ ID NO;

24, for genotype EB,

or a sequence essentially identical thereto capable of hybridizing specifically to said genotype.

8. The method according to claim 1, further characterized in that said sample is additionally incubated with at least one second oligonucleotide, said second oligonucleotide being a competitor for the hybridisation of said first oligonucleotide to DNA of another genotype of Cp. psittaci.

9. The method according to claim 8, wherein said competitor probe comprises a sequence corresponding to a sequence within the DNA of a genotype of Cp. psittaci other than the genotype to which the first probe is directed, which can be aligned with the sequence of said first probe.

10. The method according to claim 8, wherein said first and said second oligonucleotide are selected from the group consisting of:

said second oligonucleotide comprises the sequence of SEQ ID NO;

8, and said first oligonucleotide comprises the sequence of SEQ ID NO;

1;

said second oligonucleotide comprises the sequence of SEQ ID NO;

7, and said first oligonucleotide comprises the sequence of SEQ ID NO;

2;

said second oligonucleotide comprises the sequence of SEQ ID NO;

10, and wherein said first oligonucleotide comprises the sequence of SEQ ID NO;

2;

said second oligonucleotide comprises the sequence of SEQ ID NO;

9, and said first oligonucleotide comprises the sequence of SEQ ID NO;

5;

said second oligonucleotide comprises the sequence of SEQ ID NO;

11, and said first oligonucleotide comprises the sequence of SEQ ID NO;

5.

11. The method according to claim 1, wherein the binding of said first oligonucleotide is determined by PCR amplification with a forward and a reverse primer.

12. The method according to claim 11, wherein said forward and reverse primer are located about 1 to 100 bp 3′

and 5′

from said first oligonucleotide.

13. The method according to claim 11, wherein said forward and reverse primer for said PCR amplification of said first oligonucleotide are selected from the group consisting of

primers comprising the sequence of SEQ ID NO:

12 and SEQ ID NO;

13, when the first oligonucleotide comprises the sequence of SEQ ID NO;

1;

primers comprising the sequence of SEQ ID NO;

14 and SEQ ID NO;

15, when the first oligonucleotide comprises the sequence of SEQ ID NO;

2;

primers comprising the sequence of SEQ ID NO;

16 and SEQ ID NO;

17, when the first oligonucleotide comprises the sequence of SEQ ID NO;

3;

primers comprising the sequence of SEQ ID NO;

18 and SEQ ID NO;

19, when the first oligonucleotide comprises the sequence of SEQ ID NO;

4;

primers comprising the sequence of SEQ ID NO;

20 and SEQ ID NO;

21, when the first oligonucleotide comprises the sequence of SEQ ID NO;

5;

primers comprising the sequence of SEQ ID NO;

22 and SEQ ID NO;

23 when the first oligonucleotide comprises the sequence of SEQ ID NO;

6;

primers comprising the sequence of SEQ ID NO;

25 and SEQ ID NO;

26 when the first oligonucleotide comprises the sequence of SEQ ID NO;

24;

or primers which have a sequence essentially identical to said primers for PCR amplification.

14. The method according to claim 1, wherein said sample is from a bird.

15. The method according to claim 14, wherein said bird is in the stage of development in which the maternal immunity of said bird disappears.

16. The method according to claim 15, wherein said bird is a duck of about 6 weeks after hatching.

17. The method according to claim 1, for determining the efficacy of a treatment against a Cp. psittaci infection.

18. A diagnostic kit for the detection of a Cp. psittaci genotype comprising one or more oligonucleotides capable of hybridizing specifically to a sequence within the DNA of a genotype of Cp. psittaci.

19. The diagnostic kit of claim 18, wherein said one or more oligonucleotides are capable of hybridizing specifically to a sequence within the ompA gene of Cp. psittaci.

20. The diagnostic kit of claim 18, wherein said one or more oligonucleotides are capable of hybridizing specifically to a sequence within the region from about nucleotide 450 to about nucleotide 600 or from about nucleotide 900 to about 1100 of the OmpA sequence corresponding to GB accession AF269281.

21. The diagnostic kit of claim 18, wherein said genotype is the EB genotype.

22. The diagnostic kit of claim 18, comprising one or more of the oligonucleotides selected from the group consisting of:

genotype-specific oligonucleotides;

SEQ ID NO;

1, SEQ ID NO;

2, SEQ ID NO;

3, SEQ ID NO;

4, SEQ ID NO;

5, SEQ ID NO;

6 and 24; and

genotype-specific primers;

SEQ ID NO;

7, SEQ ID NO;

8, SEQ ID NO;

9, SEQ ID NO;

10, SEQ ID NO;

11, SEQ ID NO;

12, SEQ ID NO;

13, SEQ ID NO;

14, SEQ ID NO;

15, SEQ ID NO;

16, SEQ ID NO;

17, SEQ ID NO;

18, SEQ ID NO;

19, SEQ ID NO;

20, SEQ ID NO;

21, SEQ ID NO;

22, SEQ ID NO;

23, SEQ ID NO;

25 and SEQ ID NO;

26.

23. The diagnostic kit of claim 22, comprising two oligonucleotides selected from the genotype-specific oligonucleotides SEQ ID NO:

1, SEQ ID NO;

2, SEQ ID NO;

3, SEQ ID NO;

4, SEQ ID NO;

5, SEQ ID NO;

6 and 24.

24. A strain of a Cp. psittaci bacterium, designated as Cp. psittaci genotype EB, said strain characterized in that it comprises the OmpA sequence depicted in SEQ ID NO:

51.

25. A method of generating oligonucleotide sequences useful for the discrimination between at least two genotypes of Cp. psittaci, said method comprising the steps of:

a) providing a multiple alignment of a part of the genomic sequence of said at least two Cp. psittaci genotypes,

b) identifying regions which contain sequence differences within said part of the genomic sequence,

c) synthesizing one or more oligonucleotides comprising a sequence wherein said sequences differences occur.

26. The method of claim 25, wherein said genomic sequence encodes the OmpA protein.

27. The method of claim 26, wherein said part of said genomic sequence comprises the sequence from about nucleotide 450 to about nucleotide 600 or from about nucleotide 900 to about nucleotide 1100 of the OmpA sequence corresponding to GB accession AF269281.

28. The method according to claim 25, wherein one of said at least two genotypes of Cp. psittaci is the genotype EB.